cardiogenic-shock

Documents about cardiogenic-shock

• Hong Kong Cardiogenic Shock Initiative#651150ClinicalTrials.gov
• The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock#807293ClinicalTrials.gov
• BEAT-SHOCK Registry#904353ClinicalTrials.gov
• Cardiogenic Shock Intravascular Cooling Trial#835839ClinicalTrials.gov
• Hemodynamic Assessment in Cardiogenic Shock Regarding the Etiology#866478ClinicalTrials.gov
• Synchronized Cardiac Assist for Cardiogenic Shock#876275ClinicalTrials.gov
• Adrecizumab in Cardiogenic Shock#834792ClinicalTrials.gov
• Cardiogenic Shock Integrated PHenotyping for Event Reduction#810726ClinicalTrials.gov
• Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock#834169ClinicalTrials.gov
• Levosimendan for Veno-arterial ECMO Weaning#912468ClinicalTrials.gov
• Volume Responsiveness By Ultrasound Of Carotid Blood Flow In Patients With Cardiogenic Shock#827642ClinicalTrials.gov
• Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock#881624ClinicalTrials.gov
• Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine#979527ClinicalTrials.gov
• Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock#982503ClinicalTrials.gov
• Prospective Register on the Etiologies of Cardiogenic Shock and Their Prognosis at One Year.#866184ClinicalTrials.gov
• Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Cardiogenic Shock#865411ClinicalTrials.gov
• Multidisciplinary Collaborative Care System for Acute Myocardial Infarction Complicated With Cardiogenic Shock#876229ClinicalTrials.gov
• Acute Impact of the Impella CP Assist Device in Pts. With Cardiogenic Shock on the Patients Hemodynamic#896578ClinicalTrials.gov
• Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients#811626ClinicalTrials.gov
• Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy#854924ClinicalTrials.gov
• Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR#868689ClinicalTrials.gov
• Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients#875818ClinicalTrials.gov
• Age-associated outcomes in cardiogenic shock supported with microaxial flow pumps#342199HAL (France)
• Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic Shock#854069ClinicalTrials.gov
• Clinical characteristics of patients with cardiogenic shock after out-of-hospital cardiac arrest (OHCA) compared to patients with cardiogenic shock without OHCA.#214021NCBI PubMed Central
• Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City#854858ClinicalTrials.gov
• ECMO LEft Ventricle UNloading Strategy#889852ClinicalTrials.gov
• Abiomed Impella RT-DAQ - Observational Study#908393ClinicalTrials.gov
• Left Ventricular Volume Index in the Adjustment of Initial Dose of Dobutamine in Heart Failure and Cardiogenic Shock#966408ClinicalTrials.gov
• Influence of Enteral Microbiome on Mortality of Patients With Cardiogenic Shock#966785ClinicalTrials.gov
• Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO#868544ClinicalTrials.gov
• Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO)#892127ClinicalTrials.gov
• Evaluation of Acid-base Disorders and Ventilation Settings in Cardiogenic Shock and Post-cardiac Arrest Patients: Comparison With VentilO Algorithm#830641ClinicalTrials.gov
• Pressure Volume Loop#848185ClinicalTrials.gov
• Renal Resistive Index in Patients With Shock#895827ClinicalTrials.gov
• Clinical Outcomes of Contemporary IMPELLA Devices in Cardiogenic Shock and High-risk Percutaneous Coronary Intervention#866761ClinicalTrials.gov
• Pharmacological and Mechanical Support Approaches in the Management of Acute Heart Failure in the Regional Network Model for the Management of Cardiogenic Shock#917136ClinicalTrials.gov
• Oxygen Delivery Index (ODIN) Study#862171ClinicalTrials.gov
• ICU mortality of post-myocardial infarction ventricular septal defect complicated by cardiogenic shock: a retrospective multicentric cohort#268600HAL (France)
• Correlation of Cardiac Output Determined by Echocardiography and Indirect Calorimetry in Critically Ill Patients in Cardiogenic Shock on Extracorporeal Circulatory Life Support#879213ClinicalTrials.gov
• Venoarterial extracorporeal membrane oxygenation in adults with cardiogenic shock.#358275NCBI PubMed Central
• Risk Stratification in Predicting Cardiogenic Shock 30-Day Mortality admitted to ICU: beyond the Prognostic Performance of SHARC and SCAI Classifications#231733HAL (France)
• Vasoactive Intensity Predicts Mortality Beyond SCAI Staging in Cardiogenic Shock#471819HAL (France)
• Cardiogenic shock: a review of contemporary approaches and ongoing challenges.#615771NCBI PubMed Central
• The Blind Spot in Cardiogenic Shock: Patients Beyond the Current Paradigm.#404341NCBI PubMed Central
• Intra-aortic Balloon Counterpulsation (IABC) Compliance#861112ClinicalTrials.gov
• ECMOsorb Trial - Impact of a VA-ECMO in Combination With CytoSorb in Critically Ill Patients With Cardiogenic Shock#992585ClinicalTrials.gov
• Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial#847338ClinicalTrials.gov
• Machine learning predicts ICU mortality in cardiogenic shock: interpreting SOFA, lactate, and pH thresholds.#258170NCBI PubMed Central
• RUral dispaRities in prehospitAL STEMI#847927ClinicalTrials.gov